QQQ   290.80 (-1.84%)
AAPL   143.27 (-1.82%)
MSFT   243.02 (-2.07%)
META   147.71 (-2.66%)
GOOGL   97.14 (-2.24%)
AMZN   100.78 (-1.43%)
TSLA   168.10 (-5.51%)
NVDA   192.77 (-5.34%)
NIO   12.03 (-5.35%)
BABA   111.46 (-5.85%)
AMD   72.73 (-3.54%)
T   20.18 (+1.15%)
MU   62.01 (-2.91%)
F   12.93 (-2.56%)
CGC   2.84 (-3.07%)
GE   81.09 (-2.57%)
DIS   107.98 (-1.42%)
AMC   5.07 (-7.99%)
PFE   43.58 (-0.48%)
PYPL   80.22 (-1.97%)
NFLX   354.06 (-1.86%)
QQQ   290.80 (-1.84%)
AAPL   143.27 (-1.82%)
MSFT   243.02 (-2.07%)
META   147.71 (-2.66%)
GOOGL   97.14 (-2.24%)
AMZN   100.78 (-1.43%)
TSLA   168.10 (-5.51%)
NVDA   192.77 (-5.34%)
NIO   12.03 (-5.35%)
BABA   111.46 (-5.85%)
AMD   72.73 (-3.54%)
T   20.18 (+1.15%)
MU   62.01 (-2.91%)
F   12.93 (-2.56%)
CGC   2.84 (-3.07%)
GE   81.09 (-2.57%)
DIS   107.98 (-1.42%)
AMC   5.07 (-7.99%)
PFE   43.58 (-0.48%)
PYPL   80.22 (-1.97%)
NFLX   354.06 (-1.86%)
QQQ   290.80 (-1.84%)
AAPL   143.27 (-1.82%)
MSFT   243.02 (-2.07%)
META   147.71 (-2.66%)
GOOGL   97.14 (-2.24%)
AMZN   100.78 (-1.43%)
TSLA   168.10 (-5.51%)
NVDA   192.77 (-5.34%)
NIO   12.03 (-5.35%)
BABA   111.46 (-5.85%)
AMD   72.73 (-3.54%)
T   20.18 (+1.15%)
MU   62.01 (-2.91%)
F   12.93 (-2.56%)
CGC   2.84 (-3.07%)
GE   81.09 (-2.57%)
DIS   107.98 (-1.42%)
AMC   5.07 (-7.99%)
PFE   43.58 (-0.48%)
PYPL   80.22 (-1.97%)
NFLX   354.06 (-1.86%)
QQQ   290.80 (-1.84%)
AAPL   143.27 (-1.82%)
MSFT   243.02 (-2.07%)
META   147.71 (-2.66%)
GOOGL   97.14 (-2.24%)
AMZN   100.78 (-1.43%)
TSLA   168.10 (-5.51%)
NVDA   192.77 (-5.34%)
NIO   12.03 (-5.35%)
BABA   111.46 (-5.85%)
AMD   72.73 (-3.54%)
T   20.18 (+1.15%)
MU   62.01 (-2.91%)
F   12.93 (-2.56%)
CGC   2.84 (-3.07%)
GE   81.09 (-2.57%)
DIS   107.98 (-1.42%)
AMC   5.07 (-7.99%)
PFE   43.58 (-0.48%)
PYPL   80.22 (-1.97%)
NFLX   354.06 (-1.86%)
OTCMKTS:MAYNF

Mayne Pharma Group - MAYNF Stock Forecast, Price & News

$2.55
0.00 (0.00%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.55
▼
$2.55
50-Day Range
$0.15
▼
$3.91
52-Week Range
$0.12
▼
$0.29
Volume
50 shs
Average Volume
2,325 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MAYNF stock logo

About Mayne Pharma Group (OTCMKTS:MAYNF) Stock

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Receive MAYNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mayne Pharma Group and its competitors with MarketBeat's FREE daily newsletter.

MAYNF Stock News Headlines

December 7, 2022 | markets.businessinsider.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lantheus (LNTH) and Mayne Pharma Group Limited (OtherMAYNF)
December 5, 2022 | seekingalpha.com
TherapeuticsMD enters agreements to license products to Mayne Pharma
January 30, 2023 | Porter & Company (Ad)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
December 2, 2022 | finance.yahoo.com
Mayne Pharma Group Limited (ASX:MYX) Analysts Just Trimmed Their Revenue Forecasts By 19%
November 9, 2022 | finance.yahoo.com
Mayne Pharma Group (ASX:MYX) investors are sitting on a loss of 54% if they invested five years ago
September 13, 2022 | fool.com.au
Is the Mayne Pharma Group Ltd share price in the buy zone after today’s news?
August 31, 2022 | finance.yahoo.com
Analysts Are More Bearish On Mayne Pharma Group Limited (ASX:MYX) Than They Used To Be
August 16, 2022 | finance.yahoo.com
Does This Valuation Of Mayne Pharma Group Limited (ASX:MYX) Imply Investors Are Overpaying?
January 30, 2023 | Porter & Company (Ad)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
August 10, 2022 | finance.yahoo.com
Catalent's New Acquisition will Expand High-Potent Capabilities, Oral Manufacturing Capacity: Report
July 29, 2022 | finance.yahoo.com
MAYNE PHARMA AND GOODRX ANNOUNCE NEW INITIATIVE TO INCREASE AWARENESS OF NEXTSTELLIS® AND EXPAND ACCESS TO BIRTH CONTROL
May 1, 2022 | finance.yahoo.com
Mayne Pharma Group Limited (ASX:MYX) insider upped their holding by 120% earlier this year
February 8, 2022 | finance.yahoo.com
Could The Mayne Pharma Group Limited (ASX:MYX) Ownership Structure Tell Us Something Useful?
December 5, 2021 | finance.yahoo.com
Mayne Pharma Group (ASX:MYX) investors are sitting on a loss of 82% if they invested five years ago
October 19, 2021 | finance.yahoo.com
Mayne Pharma Group Limited's (ASX:MYX) Path To Profitability
September 21, 2021 | finance.yahoo.com
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
August 2, 2021 | msn.com
Mayne Pharma (ASX:MYX) share price drops on class action
June 26, 2021 | nasdaq.com
Mayne Pharma Group Limited (MAYNF)
April 15, 2021 | msn.com
Mayne Pharma shares gain as its new birth control pill wins US approval
April 15, 2021 | msn.com
Here’s why the Mayne Pharma (ASX:MYX) share price is shooting 28% higher
March 30, 2021 | au.finance.yahoo.com
$1k into $3,760: What you'd have now if you bought some of 2015's top stocks
March 26, 2021 | finance.yahoo.com
Is There An Opportunity With Mayne Pharma Group Limited's (ASX:MYX) 38% Undervaluation?
March 4, 2021 | finance.yahoo.com
Mayne Pharma launches another generic oral contraceptive
February 23, 2021 | fool.com.au
Why the Mayne Pharma (ASX:MYX) share price is dropping 5% today
See More Headlines
Receive MAYNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mayne Pharma Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:MAYNF
CUSIP
N/A
CIK
N/A
Web
www.maynepharma.com
Phone
(188) 209-2666
Fax
N/A
Employees
780
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Shawn Patrick O'Brien B.Sc
    CEO, MD & Director
  • Mr. Aaron Gray
    Chief Financial Officer
  • Ms. Kimberly Parker J.D.
    Exec. VP & Gen. Counsel
  • Mr. Brant Schofield (Age 57)
    Exec. VP of Corp. Devel.
    Comp: $705.81k
  • Dr. Andrew O. Herdman Ph.D.
    VP of Group HR
  • Mr. Stefan J. Cross (Age 50)
    Pres of International Operations
    Comp: $403.54k
  • Mr. Daniel Moore
    Exec. VP of Specialty Products & Patient Solutions
  • Mr. Gerard G. Nahum M.D.
    Chief Medical Officer
  • Mr. Hemanshu N. Pandya
    Sr. VP & Head of Generic Product Division
  • Mr. Brenton Walter
    Financial Controller

Key Competitors

View All Competitors













MAYNF Stock - Frequently Asked Questions

How have MAYNF shares performed in 2023?

Mayne Pharma Group's stock was trading at $2.50 on January 1st, 2023. Since then, MAYNF stock has increased by 2.0% and is now trading at $2.55.
View the best growth stocks for 2023 here.

Are investors shorting Mayne Pharma Group?

Mayne Pharma Group saw a drop in short interest in January. As of January 15th, there was short interest totaling 825,200 shares, a drop of 39.9% from the December 31st total of 1,372,200 shares. Based on an average daily trading volume, of 2,000 shares, the days-to-cover ratio is currently 412.6 days.
View Mayne Pharma Group's Short Interest.

When did Mayne Pharma Group's stock split?

Mayne Pharma Group shares reverse split before market open on Wednesday, January 18th 2023. The 1-20 reverse split was announced on Wednesday, January 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is Mayne Pharma Group's stock symbol?

Mayne Pharma Group trades on the OTCMKTS under the ticker symbol "MAYNF."

How do I buy shares of Mayne Pharma Group?

Shares of MAYNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mayne Pharma Group's stock price today?

One share of MAYNF stock can currently be purchased for approximately $2.55.

How many employees does Mayne Pharma Group have?

The company employs 780 workers across the globe.

How can I contact Mayne Pharma Group?

Mayne Pharma Group's mailing address is 1538 Main North Road, Salisbury, South Australia. The official website for the company is www.maynepharma.com. The company can be reached via phone at (188) 209-2666.

This page (OTCMKTS:MAYNF) was last updated on 1/30/2023 by MarketBeat.com Staff